Facebook
X
LinkedIn
Forward
2026 Tutorial on Neoplastic Hematopathology: Focus on New Classifications
Phoenix, AZ US
January 18, 2026 to January 22, 2026
Continuing in the tradition of 40+ years of tutorials, the 2026 course is designed to update physicians on the latest advances in neoplastic hematopathology. It will be conducted under the direction of Dr. Daniel A. Arber at the Hyatt Regency Phoenix Hotel from January 18-22, 2026. The program will consist of lectures, case presentations, and discussions designed to provide pathologists, pathologists-in-training, and medical oncologists/ hematologists with an in-depth discussion of diagnostic problems that arise in neoplastic hematopathology.
Target Audience
This activity is designed for pathologists and other healthcare professionals dedicated to the diagnosis of hematological malignancies.
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Identify how to evaluate and respond to diagnostic problems that arise in neoplastic hematopathology;
- State how to utilize recent advances in the classification of hematopoietic tumors;
- Discuss how to interpret and apply immunologic and molecular genetic findings in the diagnosis of neoplastic hematologic disease;
- Describe how to implement the most recent classification of hematologic neoplasms;
- Recall new discoveries that might impact future classifications of hematologic neoplasms;
- Understand the prognostic and therapeutic significance of new molecular genetic markers of these tumors.
You may also be interested in
| SUNDAY, JANUARY 18, 2026 | ||
|---|---|---|
| Time | Session | Faculty |
| 10:00 AM | Registration | |
| Afternoon Session Chairperson: Daniel A. Arber, MD | ||
| 1:00 PM | Introductory Remarks | Daniel Arber, MD |
| 1:15 PM | Normal Lymph Nodes and Reactive Hyperplasias | Rebecca King, MD |
| 2:30 PM | Introduction to the Classification of Lymphoma | James Cook, MD |
| 3:15 PM | Break | |
| 3:30 PM | Monoclonal B Lymphocytosis, Chronic Lymphocytic Leukemia and Related B-Cell Leukemia | Kathy Foucar, MD |
| 4:45 PM | Questions | |
| 5:00 PM | Case Presentations | Rebecca King, MD; James Cook, MD; Kathy Foucar, MD |
| MONDAY, JANUARY 19, 2026 | ||
| Morning Session Chairperson: Kathy Foucar, MD | ||
| 8:00 AM | Chronic T/NK Cell Leukemias | Kathy Foucar, MD |
| 8:45 AM | Lymphoplasmacytic Lymphoma and Nodal and Extranodal Marginal Zone Lymphoma | James Cook, MD |
| 9:45 AM | Questions | |
| 10:00 AM | Break | |
| 10:15 AM | Mantle Cell Lymphoma, Follicular Lymphoma and Variants | Rebecca King, MD |
| 11:15 AM | Questions | |
| 12:00 PM | Lunch | |
| Afternoon Session Chairperson: Rebecca King, MD | ||
| 1:30 PM | Peripheral T Cell Lymphoma and Anaplastic Large Cell Lymphoma | Elaine Jaffe, MD |
| 3:00 PM | Questions | |
| 3:15 PM | Break | |
| 3:30 PM | Diffuse, Aggressive B Cell Lymphomas | Rebecca King, MD |
| 4:30 PM | Lymphoma Diagnosis: A Clinician’s Perspective | Javier Munoz, MD, MBA |
| 5:30 PM | Questions | |
| TUESDAY, JANUARY 20, 2026 | ||
| Morning Session Chairperson: Amy Chadburn, MD | ||
| 8:00 AM | Immunodeficiency- and Viral-Associated Lymphoproliferations | Jonathan Said, MD |
| 9:15 AM | Splenic Tumors | Daniel Arber, MD |
| 10:00 AM | Questions | |
| 10:15 AM | Break | |
| 10:30 AM | Histiocytic Disorders | Amy Chadburn, MD |
| 11:30 AM | Questions | |
| 11:45 AM | Lunch | |
| Afternoon Session Chairperson: Jonathan Said, MD | ||
| 1:15 PM | Hodgkin Lymphoma | Amy Chadburn, MD |
| 2:15 PM | Questions | |
| 3:00 PM | Break | |
| 3:15 PM | Cutaneous Lymphomas | Jonathan Said, MD |
| 4:15 PM | Questions | |
| 4:30 PM | Case Presentations | Amy Chadburn, MD; Jonathan Said, MD |
| WEDNESDAY, JANUARY 21, 2026 | ||
| Morning Session Chairperson: Michael Borowitz, MD, PhD | ||
| 8:00 AM | Plasma Cell Neoplasms | Robert Lorsbach, MD |
| 8:45 AM | Acute Lymphoblastic Leukemias/Lymphoma and Acute Leukemias of Ambiguous Lineage | Michael Borowitz, MD, PhD |
| 10:15 AM | Questions | |
| 10:30 AM | Break | |
| 10:45 AM | Case Presentations | Michael Borowitz, MD, PhD; Robert Lorsbach, MD |
| 11:15 AM | Introduction to the Classification of Myeloid Neoplasms and Acute Leukemia | Daniel Arber, MD |
| 12:00 PM | Lunch | |
| Afternoon Session Chairperson: Adam Bagg, MD | ||
| 1:30 PM | Chronic Myeloid Leukemia | Adam Bagg, MD |
| 2:15 PM | BCR: ABL1--negative Myeloproliferative Neoplasms | Attilio Orazi, MD |
| 3:15 PM | Questions | |
| 3:30 PM | Break | |
| 3:45 PM | Eosinophilic Disorders | Adam Bagg, MD |
| 4:30 PM | Questions | |
| 4:45 PM | Case Presentations | Adam Bagg, MD; Attilio Orazi, MD |
| THURSDAY, JANUARY 22, 2026 | ||
| Morning Session Chairperson: Robert Lorsbach, MD | ||
| 8:00 AM | Clonal Cytopenias and Myelodysplastic Syndrome | Robert Hasserjian, MD |
| 9:00 AM | Pediatric and Germline Predisposition Syndromes | Robert Lorsbach, MD |
| 9:45 AM | Questions | |
| 10:00 AM | Break | |
| 10:15 AM | Myelodysplastic/Myeloproliferative Neoplasms | Attilio Orazi, MD |
| 11:15 AM | Questions | |
| 11:30 AM | Case Presentations | Robert Hasserjian, MD; Robert Lorsbach, MD |
| 12:00 PM | Lunch | |
| Afternoon Session Chairperson: Daniel Arber, MD | ||
| 1:30 PM | Acute Myeloid Leukemias | Daniel Arber, MD |
| 2:30 PM | Mastocytosis | Attilio Orazi, MD |
| 3:30 PM | Questions | |
| 3:45 PM | Case Presentations | Daniel Arber, MD; Attilio Orazi, MD |
| 4:15 PM | Questions | |
| 4:30 PM | Concluding Remarks | |
The agenda is subject to change.
Hyatt Regency Phoenix Hotel
122 N 2nd St
Phoenix, AZ
85004
United States
WANT TO KNOW MORE?
For questions about the conference, contact Brittany Dickens via email.
BOOKING INFORMATION
Accommodations have been reserved for Tutorial participants at the Hyatt Regency Phoenix Hotel. Note that a one-night deposit may be required. To make reservations, follow this link: https://www.hyatt.com/en-US/group-booking/PHXRP/G-UNPA.
Participants may also call 1-602-333-0000 to make reservations. Advise the reservations desk that you will be attending The University of Chicago Tutorial on Neoplastic Hematopathology from January 18-22, 2026, to receive the group rate. A confirmation number will be immediately assigned. The special daily rate for this meeting is $239/night (single/double). We strongly encourage online reservation bookings, as the hotel may charge a $10.00 booking fee for all reservations made via phone.
Reservations made after December 29, 2025, will be accepted on a space-available basis, and rooms will not be available at the discounted group rate. Please make your reservations early!
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 773-834-2555 or via email at [email protected].
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
COURSE DIRECTOR
Chair, Department of Pathology
University of Chicago
University of Chicago
ASSOCIATE COURSE DIRECTOR
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, the University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 33.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Pathology Lifelong Learning (CME) Credit
This activity has been registered to offer credit in the American Board of Pathology’s Continuing Certification program. Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 33.75 CME credits. Participants will earn credits equivalent to the amount of AMA PRA Category 1 Credits™ claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABPath Lifelong Learning (CME) credit.
Other Health Professional Credit
Other Participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 33.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Pathology Lifelong Learning (CME) Credit
This activity has been registered to offer credit in the American Board of Pathology’s Continuing Certification program. Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 33.75 CME credits. Participants will earn credits equivalent to the amount of AMA PRA Category 1 Credits™ claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABPath Lifelong Learning (CME) credit.
Other Health Professional Credit
Other Participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABPath. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.
EXHIBIT OPPORTUNITIES AVAILABLE
This conference offers a tremendous opportunity to highlight your company's products, services, and achievements in front of a wide array of key decision makers. Increase your company profile by participating as an exhibitor at this exciting event!
Last year's conference drew over 150 participants, including pathologists and other healthcare professionals specializing in hematology. Also in attendance will be our course faculty, including 14 world-renowned experts from across the country.
Download the prospectus (coming soon!) or contact Brittany Dickens - [email protected] or 773-834-2555. We hope to see you there!
Last year's conference drew over 150 participants, including pathologists and other healthcare professionals specializing in hematology. Also in attendance will be our course faculty, including 14 world-renowned experts from across the country.
Download the prospectus (coming soon!) or contact Brittany Dickens - [email protected] or 773-834-2555. We hope to see you there!
HOW TO REGISTER
Please log in or create an account to register. Once logged in, select the registration type that best suits you. For help, view our 
registration guide.
registration guide.- Registration will begin: Sunday, January 18, 2026, from 10:00 a.m. to 5:00 p.m. & Monday, January 19, 2026, from 7:00 to 7:50 a.m., in the Phoenix Ballroom Foyer. The conference will run from 1:00 p.m. to 5:30 p.m. Sunday and Monday through Thursday 8:00 a.m. to 5:30 p.m.
- A continental-style breakfast will be provided each morning at 7:00 a.m. and refreshments will be served during breaks in the Atrium 1, Hanson & Cameron Foyer.
Enter the discount code during the registration process to receive the early rate!
Profession Type | Before 11/21/2025 | Discount Code | After 11/21/2025 |
|---|---|---|---|
Practicing Physician | $1650 | TNHE26 | $1750 |
| Other Healthcare Professionals | $1650 | TNHE26 | $1750 |
Physicians in Training | $900 | TNHE26 | $1000 |
| Industry | $1650 | TNHE26 | $1750 |
CANCELLATION POLICY: If you cancel your participation in this conference, your registration fee less a $150 administrative fee will be refunded when written notification is received by December 31, 2025. No refunds will be made after December 31, 2025. | |||
CLAIMING CREDIT
At the end of the course, the credit-claiming process will unlock. Return to this page and click on "Complete Activity" to proceed.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABPath. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.
Please login or create an account to proceed.